X0303 4 2011-06-14 0 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001460684 Camerini Roberto 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 1 0 0 0 Common Stock 2011-06-14 4 M 0 14710 1.24 A 14710 D Common Stock 2011-06-14 4 S 0 14710 5.0108 D 0 D Common Stock 2011-06-14 4 M 0 18624 1.24 A 18624 D Common Stock 2011-06-14 4 S 0 18624 4.9573 D 0 D Common Stock 2011-06-14 4 M 0 30000 3.01 A 30000 D Common Stock 2011-06-14 4 S 0 30000 4.9573 D 0 D Common Stock 2011-06-14 4 M 0 5000 2.23 A 5000 D Common Stock 2011-06-14 4 S 0 5000 4.9573 D 0 D Non-Qualified Stock Option (right to buy) 1.24 2011-06-14 4 M 0 14710 0 D 2019-03-30 Common Stock 14710 35290 D Non-Qualified Stock Option (right to buy) 1.24 2011-06-14 4 M 0 18624 0 D 2019-03-30 Common Stock 18624 16666 D Non-Qualified Stock Option (right to buy) 2.23 2011-06-14 4 M 0 5000 0 D 2019-06-09 Common Stock 5000 0 D Non-Qualified Stock Option (right to buy) 3.01 2011-06-14 4 M 0 30000 0 D 2020-06-10 Common Stock 30000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.05. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.90 to $5.00. Granted under the Issuer's 2004 Outside Directors Stock Option Plan. Shares shall become exercisable in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Outside Director's continuous service on Issuer's Board of Directors. Each option shall vest and become exercisable at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant except that, in the event of a change in control, any unexercisable or unvested portions of outstanding options shall be immediately exercisable and vested in full as of the date ten (10) days prior to the change in control, regardless of whether the option is assumed or substituted for by the acquirer. By: /s/ Gary Titus, Attorney-in-Fact For: Roberto Camerini 2011-06-16